Bemarituzumab

Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.

Product Specifications

CAS Number

1952272-74-0

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

FGFR

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

AMM14287VCF 100 µg

XTP4 (MIEN1) Mouse Monoclonal Antibody [Clone ID: LBI2D5]

Ask

View Details

YP-W80216-01 48 Tests

Porcine cytokine-induced neutrophil chemoattractant-1 (CINC-1) ELISA Kit

Ask

View Details

YP-W80216-02 96 Tests

Porcine cytokine-induced neutrophil chemoattractant-1 (CINC-1) ELISA Kit

Ask

View Details

TRC-I694240-1G 1 g

Iodocholine

Ask

View Details

GTR15265889 1 Vial

Lentiviral mouse Sephs1 shRNA (UAS) - Lentiviral mouse Sephs1 shRNA (UAS) (25)

Ask

View Details